The levels of Cxcl13, a key B cell chemoattractant known to be reduced in MASH-HCC17, were elevated in tumours from both Acly-KO and EVT0185-treated mice (Fig. 4j,p), a finding replicated in publicly available RNA-seq data from WT and Acly-KO DEN-induced tumours cultured in vitro10 (GSE223966; Extended Data Fig. 8f). This evidence concerns the gene CXCL13 and neoplasm.